Monthly Archives: August 2020

The Importance of Integrating Mental Health Care Services Into HIV Comprehensive Care

According to a study published in the American Journal of Managed Care integrating mental health care access into a comprehensive care plan improves the likelihood of medication adherence among people living with HIV. The study, conducted in 2018, utilized a cross-sectional survey to identify needs among people living with HIV in the Midwestern region of the United States and distinguished mental health care services (MHCS) by those in need of and those already receiving services. Of the...

Southern HIV/AIDS Awareness Day 2020

Thursday, August 20, marks Southern HIV/AIDS Awareness Day (SHAAD) 2020. Launched last year by the Southern AIDS Coalition, the day presents an opportunity to draw attention to the epidemic in the South, which comprises 51% of new HIV diagnoses annually, although only 38% of the U.S. population lives there.  The Centers for Disease Control and Prevention (CDC) defines the South as including Alabama, Arkansas, Delaware, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma,...

Life Lessons for Those Newly Diagnosed With HIV

Life can sometimes feel like an endless series of highs and lows, and we hardly notice how each one propels us from one moment to the next. While the thrill of achievement is fleeting at best, the fallout from a mistake can sometimes seem like an endless free fall. When it comes to HIV, those who live with the virus often feel as if it’s a mistake they can never make up for. It may feel like it will forever diminish...

New HIV Medication Approved for Those at Risk of Advancing to AIDS

The U.S. Food and Drug Administration approved a new drug that combats drug resistance among “heavily treatment-experienced” HIV-positive people, drugmaker ViiV Healthcare announced Thursday. The medication, called fostemsavir and marketed under the name Rukobia, is to be used in combination with other antiretroviral medications and will specifically address those whose regimens are not succeeding because of resistance, intolerance, or safety considerations. “There is a small group of heavily treatment-experienced adults living with HIV who are not able to maintain viral suppression...